Frontida BioPharm, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Frontida BioPharm, Inc. - overview

Established

2015

Location

Philadelphia, PA, US

Primary Industry

Biotechnology

About

Founded in 2015 and based in Pennsylvania, US, Frontida BioPharm, Inc. is a biotechnology company that provides drug delivery technologies, product development, and manufacturing services to the biopharmaceutical industry. The company manufactures oral solid dose, liquids, and suspensions products and also offers clinical trial materials manufacturing, commercial packaging, warehousing, and stability services. In December 2021, Adare Pharma Solutions, a portfolio company of Frazier Healthcare Partners and Thomas H Lee Partners, acquired Frontida BioPharm, Inc.


Frontida was launched by founding management team members of Frontage Laboratories. After the acquisition, the combined company will offer an expanded suite of solutions for complex oral formulations, such as taste masking, controlled release, high potency formulation manufacturing, and bioavailability enhancement.


Current Investors

Adare Pharma Solutions

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Pharmaceutical Research & Development

Verticals

Manufacturing

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Frontida BioPharm, Inc. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
N/ACompleted1100 Orthodox Street, 7722 Dungan Road-
Add-onCompletedFrontida BioPharm, Inc.-

Displaying 1 - 2 of 2

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.